Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fem-1 homolog A pseudogene" (ENSG00000280172) refers to a non-functional genomic DNA sequence that displays strong homology to the protein-coding Fem-1 homolog A (FEM1A) gene but lacks the ability to produce a functional protein product due to mutations such as frameshifts or premature stop codons, or lack of regulatory elements[2][3][7]. Pseudogenes are generally considered non-coding, are not regarded as drug targets, and have no proven direct role in disease or drug interaction[2][3][7]. No conventional abbreviations are assigned to pseudogenes, and their standard classification is "pseudogene." While rare functional pseudogenes exist, most are not targets for therapeutic interventions and have not been shown to interact with drugs or serve as biomarkers[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fem-1 homolog A pseudogene.